171 related articles for article (PubMed ID: 33746388)
1. Arginase/nitric oxide modifications using live non-pathogenic
Badirzadeh A; Montakhab-Yeganeh H; Miandoabi T
J Parasit Dis; 2021 Mar; 45(1):65-71. PubMed ID: 33746388
[TBL] [Abstract][Full Text] [Related]
2. Leishmania tarentolae expressing CXCL-10 as an efficient immunotherapy approach against Leishmania major-infected BALB/c mice.
Montakhab-Yeganeh H; Abdossamadi Z; Zahedifard F; Taslimi Y; Badirzadeh A; Saljoughian N; Taheri T; Taghikhani M; Rafati S
Parasite Immunol; 2017 Oct; 39(10):. PubMed ID: 28833211
[TBL] [Abstract][Full Text] [Related]
3. Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites.
Badirzadeh A; Taheri T; Taslimi Y; Abdossamadi Z; Heidari-Kharaji M; Gholami E; Sedaghat B; Niyyati M; Rafati S
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005774. PubMed ID: 28708893
[TBL] [Abstract][Full Text] [Related]
4. Antitumor Effect of IP-10 by Using Two Different Approaches: Live Delivery System and Gene Therapy.
Taslimi Y; Zahedifard F; Habibzadeh S; Taheri T; Abbaspour H; Sadeghipour A; Mohit E; Rafati S
J Breast Cancer; 2016 Mar; 19(1):34-44. PubMed ID: 27066094
[TBL] [Abstract][Full Text] [Related]
5. Isolation, characterization, and functional study of extracellular vesicles derived from
Shokouhy M; Sarvnaz H; Taslimi Y; Lajevardi MS; Habibzadeh S; Mizbani A; Shekari F; Behbahani M; Torrecilhas AC; Rafati S
Front Cell Infect Microbiol; 2022; 12():921410. PubMed ID: 35992172
[No Abstract] [Full Text] [Related]
6. Metabolomic Reprogramming of C57BL/6-Macrophages during Early Infection with
Mamani-Huanca M; Muxel SM; Acuña SM; Floeter-Winter LM; Barbas C; López-Gonzálvez Á
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206906
[No Abstract] [Full Text] [Related]
7. The inhibition of arginase by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages.
Iniesta V; Gómez-Nieto LC; Corraliza I
J Exp Med; 2001 Mar; 193(6):777-84. PubMed ID: 11257143
[TBL] [Abstract][Full Text] [Related]
8. Leishmania tarentolae: a vaccine platform to target dendritic cells and a surrogate pathogen for next generation vaccine research in leishmaniases and viral infections.
Bandi C; Mendoza-Roldan JA; Otranto D; Alvaro A; Louzada-Flores VN; Pajoro M; Varotto-Boccazzi I; Brilli M; Manenti A; Montomoli E; Zuccotti G; Epis S
Parasit Vectors; 2023 Jan; 16(1):35. PubMed ID: 36703216
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a new live recombinant vaccine against cutaneous leishmaniasis in BALB/c mice.
Salari S; Sharifi I; Keyhani AR; Ghasemi Nejad Almani P
Parasit Vectors; 2020 Aug; 13(1):415. PubMed ID: 32787908
[TBL] [Abstract][Full Text] [Related]
10. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
[TBL] [Abstract][Full Text] [Related]
11. Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis.
Saljoughian N; Taheri T; Zahedifard F; Taslimi Y; Doustdari F; Bolhassani A; Doroud D; Azizi H; Heidari K; Vasei M; Namvar Asl N; Papadopoulou B; Rafati S
PLoS Negl Trop Dis; 2013; 7(4):e2174. PubMed ID: 23638195
[TBL] [Abstract][Full Text] [Related]
12. l-Arginine Uptake by Cationic Amino Acid Transporter Promotes Intra-Macrophage Survival of
Mandal A; Das S; Kumar A; Roy S; Verma S; Ghosh AK; Singh R; Abhishek K; Saini S; Sardar AH; Purkait B; Kumar A; Mandal C; Das P
Front Immunol; 2017; 8():839. PubMed ID: 28798743
[TBL] [Abstract][Full Text] [Related]
13. Enhanced protective efficacy of nonpathogenic recombinant leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigen.
Zahedifard F; Gholami E; Taheri T; Taslimi Y; Doustdari F; Seyed N; Torkashvand F; Meneses C; Papadopoulou B; Kamhawi S; Valenzuela JG; Rafati S
PLoS Negl Trop Dis; 2014 Mar; 8(3):e2751. PubMed ID: 24675711
[TBL] [Abstract][Full Text] [Related]
14. Live Leishmania tarentolae secreting HNP1 as an immunotherapeutic tool against Leishmania infection in BALB/c mice.
Abdossamadi Z; Taheri T; Seyed N; Montakhab-Yeganeh H; Zahedifard F; Taslimi Y; Habibzadeh S; Gholami E; Gharibzadeh S; Rafati S
Immunotherapy; 2017 Oct; 9(13):1089-1102. PubMed ID: 29032739
[TBL] [Abstract][Full Text] [Related]
15. Effect of A2 gene on infectivity of the nonpathogenic parasite Leishmania tarentolae.
Mizbani A; Taslimi Y; Zahedifard F; Taheri T; Rafati S
Parasitol Res; 2011 Sep; 109(3):793-9. PubMed ID: 21442256
[TBL] [Abstract][Full Text] [Related]
16. Leishmania tarentolae: utility as an in vitro model for screening of antileishmanial agents.
Taylor VM; Muñoz DL; Cedeño DL; Vélez ID; Jones MA; Robledo SM
Exp Parasitol; 2010 Dec; 126(4):471-5. PubMed ID: 20685203
[TBL] [Abstract][Full Text] [Related]
17. An effect of parasite-encoded arginase on the outcome of murine cutaneous leishmaniasis.
Gaur U; Roberts SC; Dalvi RP; Corraliza I; Ullman B; Wilson ME
J Immunol; 2007 Dec; 179(12):8446-53. PubMed ID: 18056391
[TBL] [Abstract][Full Text] [Related]
18. Detection of Leishmania tarentolae in lizards, sand flies and dogs in southern Italy, where Leishmania infantum is endemic: hindrances and opportunities.
Mendoza-Roldan JA; Latrofa MS; Iatta R; R S Manoj R; Panarese R; Annoscia G; Pombi M; Zatelli A; Beugnet F; Otranto D
Parasit Vectors; 2021 Sep; 14(1):461. PubMed ID: 34493323
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model.
Salehi M; Taheri T; Mohit E; Zahedifard F; Seyed N; Taslimi Y; Sattari M; Bolhassani A; Rafati S
Immunotherapy; 2012 Nov; 4(11):1107-20. PubMed ID: 23194361
[TBL] [Abstract][Full Text] [Related]
20. Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model.
Katebi A; Gholami E; Taheri T; Zahedifard F; Habibzadeh S; Taslimi Y; Shokri F; Papadopoulou B; Kamhawi S; Valenzuela JG; Rafati S
Mol Immunol; 2015 Oct; 67(2 Pt B):501-11. PubMed ID: 26298575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
